Snapshot
- Ticker: HUBS (NYSE)
- Bucket: Software in the AI Crosshairs
- Q1 2026 position: 232,115 shares, $56.7M, 1.13% of 13F — not top-20
- HQ: Cambridge, Massachusetts
- What it does: Customer platform (CRM, marketing, sales, service) for small and mid-market businesses, sold on a freemium-to-suite subscription model.
Business Overview
HubSpot built its franchise on inbound marketing software and has expanded into a multi-hub “customer platform” — Marketing, Sales, Service, Content, Operations and Commerce hubs on a shared CRM — aimed at SMBs and the mid-market. Revenue is almost entirely subscription: of FY2025’s 3.06B was subscription.
The AI story is the whole fight here. HubSpot is shipping its Breeze family of AI agents and copilots across the platform while trying to hold profitability — non-GAAP operating income reached 460.2M in 2024), and GAAP operating margin crossed into positive territory (0.2%) for the first time. Q1 2026 showed no demand cliff: revenue of 32.6M versus a loss a year earlier.
The stock told a different story than the fundamentals through 2025: HUBS derated severely as the market repriced seat-based SMB software as the most exposed category to AI agents, with implied prices in Atreides’ own filings falling from ~244/share (Q1 2026).
Financial Trajectory
| Period | Revenue | Growth | Notes |
|---|---|---|---|
| FY2024 | ~$2.63B | ~21% | GAAP op margin (2.6)% |
| FY2025 | $3.13B | 19% | GAAP op margin 0.2%; non-GAAP op income $581.9M |
| Q1 2026 | $881.0M | 23% (18% cc) | GAAP net income 2.73 |
Why Atreides Owns It
HubSpot is arguably the purest public referendum on Baker’s SaaS thesis. His frame (Invest Like the Best EP.451, Dec 2025): incumbent SaaS faces a “life or death decision” — sacrifice margin to ship AI agents, or be undercut by lean AI-native startups — and “anything you can verify, you can automate.” CRM workflows for SMBs sit squarely in that crosshair, which is why the market took the stock down ~70% from its early-2025 highs even as revenue compounded at ~20%.
Atreides has traded the controversy rather than marrying a side. It bought a 468/share) as the AI-fear derating got going, exited entirely in Q4 2025, then re-entered in Q1 2026 at roughly half the price (~200s, HubSpot is priced as an AI loser, while Breeze gives it a credible path to being a margin-sacrificing survivor in exactly the way Baker says is necessary. The whipsaw also fits the fund’s broader Q1 2026 software rotation — out of dev-tools casualties (GitLab), into names where the AI-displacement risk looks overdiscounted.
Position History
| Quarter | Type | Shares/Notional | Value | % of 13F |
|---|---|---|---|---|
| Q4 2024 | — | not held | — | — |
| Q1 2025 | — | not held | — | — |
| Q2 2025 | — | not held | — | — |
| Q3 2025 | Common | 243,434 | $113,878,425 | 2.22% |
| Q4 2025 | — | not held | — | — |
| Q1 2026 | Common | 232,115 | $56,659,272 | 1.13% |
A clean whipsaw: a 2.2%-of-book entry in Q3 2025, full exit one quarter later, then a re-entry in Q1 2026 at almost the identical share count but half the dollar value — the difference is entirely the stock’s collapse. The Q4 exit avoided much of the drawdown; the Q1 re-entry is a fresh bet that the derating overshot.
Risks
- The AI bear case may simply be right: agentic CRM from AI-native startups (or from OpenAI/Microsoft platform layers) could structurally shrink seat counts and pricing in SMB software.
- SMB customer base is the most macro-sensitive and churn-prone segment of enterprise software.
- Margin sacrifice is real: if Breeze succeeds by Baker’s own logic, it does so by trading margin for survival — the FY2025 margin inflection could reverse.
- Whipsaw risk for the fund: Atreides has already been wrong-footed once on timing here; a 1.1% position implies conviction is moderate.
- Competition from Salesforce moving down-market with Agentforce pricing pressure.